We are live on ! Find out more
SURF

Surface Oncology, Inc. Common Stock
SURF

Delisted

SURF was delisted on the 7th of September, 2023.

Back to rankings

34 hedge funds and large institutions have $26.1M invested in Surface Oncology, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more capital invested

Capital invested by funds: $20.9M → $26.1M (+$5.19M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 35 → 34 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

75% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 16

Holders
34
Holders Change
-1
Holders Change %
-2.86%
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
4
Reduced
16
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$233K
2
Squarepoint
Squarepoint
New York
+$90.8K
3
PAM
PVG Asset Management
Colorado
+$45.2K
4
BCM
Beddow Capital Management
Wyoming
+$41.6K
5
HF
HRT Financial
New York
+$33.2K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$520K
2
EC
EcoR1 Capital
California
-$412K
3
Millennium Management
Millennium Management
New York
-$319K
4
Victory Capital Management
Victory Capital Management
Texas
-$152K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$104K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
26
Spark Investment Management
New York
$19K -$13.5K -8,100 -43%
TRCT
27
Tower Research Capital (TRC)
New York
$11K -$32.7K -19,656 -77%
Deutsche Bank
28
Deutsche Bank
Germany
$8K -$8.52K -5,116 -53%
MAM
29
Meeder Asset Management
Ohio
$8K -$485 -291 -6%
BBHC
30
Brown Brothers Harriman & Co
New York
$3K – – –
Citigroup
31
Citigroup
New York
$2K +$10 +6 +0.5%
PAM
32
Panagora Asset Management
Massachusetts
$2K +$1.41K +848 New
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$122 -$2.27K -1,364 -95%
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
– -$104K -73,402 Closed
Bank of New York Mellon
35
Bank of New York Mellon
New York
– -$44K -30,979 Closed
State Street
36
State Street
Massachusetts
– -$18K -12,724 Closed
Russell Investments Group
37
Russell Investments Group
United Kingdom
– -$10K -6,909 Closed
UBS Group
38
UBS Group
Switzerland
– -$2K -1,291 Closed
Federated Hermes
39
Federated Hermes
Pennsylvania
– -$1K -734 Closed
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
– +$220 +132 New
1
2

SURF Hedge Fund Activity: Q4 2019 in Review

34 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q4 2019, worth a combined $26.1M — up 25% from $20.9M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SURF and 6 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $233K. The largest seller was BlackRock, cutting an estimated $520K.

  • 34 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q4 2019, down from 35 in Q3 2019.
  • Funds reported $26.1M of Surface Oncology, Inc. Common Stock stock for Q4 2019, up 25% quarter-over-quarter.
  • 6 funds opened new Surface Oncology, Inc. Common Stock positions in Q4 2019 and 7 closed out, a net change of -1 holder.
  • The largest Surface Oncology, Inc. Common Stock buyer in Q4 2019 was Renaissance Technologies, an estimated $233K added.
  • The largest Surface Oncology, Inc. Common Stock seller in Q4 2019 was BlackRock, an estimated $520K sold.

Based on aggregated 13F filings for Q4 2019.